Immunologically measurable insulin (IMI) in normal, obese and obese, diabetic subjects after intravenous administration of glucose, tolbutamide and glucagon.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.